The drug maker AstraZeneca has been marketing its coronavirus vaccine at not-for-gain prices … Business November 13, 2021 AstraZeneca Says it Will Start Profiting From its Vaccine
“The optimum stages of NIH are really involved,” said Dr. Avindra Nath, intramural … Health September 15, 2021 AstraZeneca vaccine trial: NIH ‘very concerned’ about serious side effect in vaccine trial
